Bioreductive prodrugs for cancer therapy.

Suppr

超能文献

作者信息

Seddon Beatrice, Kelland Lloyd R, Workman Paul

机构信息

Cancer Research UK Centre for Cancer Therapeutics, Institute of Cancer Research, Sutton, Surrey, UK.

出版信息

Methods Mol Med. 2004;90:515-42. doi: 10.1385/1-59259-429-8:515.

DOI:10.1385/1-59259-429-8:515

PMID:14657582

Abstract

摘要

相似文献

Bioreductive prodrugs for cancer therapy.

Methods Mol Med. 2004;90:515-42. doi: 10.1385/1-59259-429-8:515.

Bioreductive mechanisms.

Int J Radiat Oncol Biol Phys. 1992;22(4):631-7. doi: 10.1016/0360-3016(92)90493-2.

Tumor sensitization to purine analogs by E. coli PNP.

Methods Mol Med. 2004;90:223-45. doi: 10.1385/1-59259-429-8:223.

Bioreductive drugs in cancer therapy.

BJR Suppl. 1992;24:128-36.

In vitro and in vivo models for evaluation of GDEPT: quantifying bystander killing in cell cultures and tumors.

Methods Mol Med. 2004;90:403-31. doi: 10.1385/1-59259-429-8:403.

Bioreductive therapy.

Int J Radiat Oncol Biol Phys. 1992;22(4):685-7. doi: 10.1016/0360-3016(92)90503-a.

A novel multifunctional 2-nitroimidazole-based bioreductive linker and its application in hypoxia-activated prodrugs.

Bioorg Chem. 2020 Aug;101:103975. doi: 10.1016/j.bioorg.2020.103975. Epub 2020 May 26.

Hypoxia: targeting the tumour.

Anticancer Agents Med Chem. 2006 Jul;6(4):281-6. doi: 10.2174/187152006777698169.

The nitroreductase/CB1954 enzyme-prodrug system.

Methods Mol Med. 2004;90:459-77. doi: 10.1385/1-59259-429-8:459.

Combination suicide gene therapy.

Methods Mol Med. 2004;90:345-52. doi: 10.1385/1-59259-429-8:345.

引用本文的文献

Cyclic Dichalcogenides Extend the Reach of Bioreductive Prodrugs to Harness Thiol/Disulfide Oxidoreductases: Applications to -Duocarmycins Targeting the Thioredoxin System.

ACS Cent Sci. 2023 Mar 28;9(4):763-776. doi: 10.1021/acscentsci.2c01465. eCollection 2023 Apr 26.

ROS-activated anticancer prodrugs: a new strategy for tumor-specific damage.

Ther Deliv. 2012 Jul;3(7):823-33. doi: 10.4155/tde.12.61.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

Bioreductive prodrugs for cancer therapy.

Methods Mol Med. 2004;90:515-42. doi: 10.1385/1-59259-429-8:515.

Bioreductive mechanisms.

Int J Radiat Oncol Biol Phys. 1992;22(4):631-7. doi: 10.1016/0360-3016(92)90493-2.

Tumor sensitization to purine analogs by E. coli PNP.

Methods Mol Med. 2004;90:223-45. doi: 10.1385/1-59259-429-8:223.

Bioreductive drugs in cancer therapy.

BJR Suppl. 1992;24:128-36.

In vitro and in vivo models for evaluation of GDEPT: quantifying bystander killing in cell cultures and tumors.

Methods Mol Med. 2004;90:403-31. doi: 10.1385/1-59259-429-8:403.

Bioreductive therapy.

Int J Radiat Oncol Biol Phys. 1992;22(4):685-7. doi: 10.1016/0360-3016(92)90503-a.

A novel multifunctional 2-nitroimidazole-based bioreductive linker and its application in hypoxia-activated prodrugs.

Bioorg Chem. 2020 Aug;101:103975. doi: 10.1016/j.bioorg.2020.103975. Epub 2020 May 26.

Hypoxia: targeting the tumour.

Anticancer Agents Med Chem. 2006 Jul;6(4):281-6. doi: 10.2174/187152006777698169.

The nitroreductase/CB1954 enzyme-prodrug system.

Methods Mol Med. 2004;90:459-77. doi: 10.1385/1-59259-429-8:459.

Combination suicide gene therapy.

Methods Mol Med. 2004;90:345-52. doi: 10.1385/1-59259-429-8:345.

引用本文的文献

Cyclic Dichalcogenides Extend the Reach of Bioreductive Prodrugs to Harness Thiol/Disulfide Oxidoreductases: Applications to -Duocarmycins Targeting the Thioredoxin System.

ACS Cent Sci. 2023 Mar 28;9(4):763-776. doi: 10.1021/acscentsci.2c01465. eCollection 2023 Apr 26.

ROS-activated anticancer prodrugs: a new strategy for tumor-specific damage.

Ther Deliv. 2012 Jul;3(7):823-33. doi: 10.4155/tde.12.61.